Navigation Links
BIKAM and Dalton Medicinal Chemistry Expand and Renew Research Agreement
Date:10/29/2009

BIKAM, pioneers in the discovery and development of potential therapeutic agents for the treatment of degenerative eye diseases and ocular disorders and Dalton Medicinal Chemistry have jointly announced a renewal of their exclusive worldwide collaboration and agreement to discover and develop new ophthalmology therapeutics.

Boston, MA and Toronto, ON (PRWEB) October 29, 2009 -- BIKAM, pioneers in the discovery and development of potential therapeutic agents for the treatment of degenerative eye diseases and ocular disorders and Dalton Medicinal Chemistry have jointly announced a renewal of their exclusive worldwide collaboration and agreement to discover and develop new ophthalmology therapeutics.

Dalton Medicinal Chemistry will continue to utilize their proprietary insights to advance several novel classes of compounds against selected BIKAM targets. BIKAM will advance these agents with their growing cutting edge battery of biological assays and delivery methodologies.

David Garvey, VP, Chemistry at BIKAM commented: “For the past 18 months we have had a very productive relationship with the Dalton Medicinal Chemistry team”.

Judd Berman, Co-founder of Dalton Medicinal Chemistry, said: “It’s been exceptionally exciting to work with the talented scientists at BIKAM to advance these important programs towards clinical development and beyond. We are delighted to have the opportunity to further contribute to these pioneering programs.”

About BIKAM
BIKAM, Inc. is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of degenerative eye diseases and disorders. BIKAM is building a portfolio of product candidates based on patented technologies that were identified at the University of Florida, Gainesville. BIKAM investors include HealthCare Ventures, CHL Medical Partners and Fidelity Biosciences.

About Dalton Medicinal Chemistry & Dalton Pharma Services
Dalton Medicinal Chemistry Incorporated (DMC) was established to offer select partners medicinal chemistry capabilities in design and synthesis of new chemical entities.
DMC focuses on quality, creativity and speed in the delivery of innovative, high quality medicinal chemistry capabilities for the identification of new chemical entities which advance our clients' drug discovery programs. Our contributions to clinical development candidate selection include SAR elucidation, design and synthesis of focused compound arrays, hit to lead, lead optimization and generation of intellectual property. DMC has full access to Dalton Pharma Services (DPS) and its world class synthetic laboratories equipped with the latest technology in modern synthetic chemistry, structural determination and purity assessment.

Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

Contact:
BIKAM, Inc.
David Garvey
dgarvey (at) bikampharma (dot) com

Dalton Medicinal Chemistry
Peter Pekos
416-661-2102
www.dalton.com

###

Read the full story at http://www.prweb.com/releases/Dalton_BIKAM/Medicinal_Chemistry/prweb3131644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Dalton Pharma Services Adds Formulation Development Services
2. Dalton Pharma Services Adds Formulation Development Services
3. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
4. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
5. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
6. Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
7. PartsSource President & CEO A. Ray Dalton Named Harvard School of Business Entrepreneur of the Year
8. PartsSource President & CEO A. Ray Dalton Wins Innovation in Business Award
9. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
10. Medicinal products susceptible to dose dumping should be fully tested
11. Medithrive Announces the Grand Opening of Its San Francisco Medicinal Marijuana Dispensary
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BIKAM and Dalton Medicinal Chemistry Expand and Renew Research Agreement
(Date:5/4/2016)... Hills, CA (PRWEB) , ... May 04, 2016 , ... ... care that ex-supermodel Janice Dickinson needed following breast cancer surgery. In March 2016, the ... situ, a type of breast cancer that occurs in the milk ducts, according to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... medical coding, billing and compliance. In upcoming months, AudioEducator has lined up some ... Every conference is designed to give complete compliance know-how and practical, easy-to-apply advice. ...
(Date:5/4/2016)... ... May 03, 2016 – (PRWEB) May ... and child products, today revealed the non-toxic benefits of its Tutti ... deal with teething pain is just part of the story. These ... are BPA-, PVC-, and phthalate-free. , “Many baby toys contain ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... they acquired Pocono Sterilizer, an equipment sterilization service and sales company located in ... provides medical and research-related equipment and asset management services to the medical and ...
(Date:5/4/2016)... Clara, California (PRWEB) , ... May 04, 2016 ... ... organized by United Scientific Group is scheduled on July 25-27, 2016 at Las ... and other health care professionals from educational institutes and research organizations across the ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... TUSTIN, Calif. , May 3, 2016 /PRNewswire/ ... science teaching tool that shows how a cleanroom ... for classroom discussions about science and technology. ... Manager said, "As a technology company, SSF enthusiastically ... program to help educators foster the next generation ...
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)... , May 2, 2016  While nearly three-quarters ... osteoporosis can have on their health, only about half ... according to the results of a new survey announced ... mark the start of National Osteoporosis Month, Hologic is ... which affects nearly 56 million Americans. Osteoporosis ...
Breaking Medicine Technology: